BeStock  
Stocks › Biotechnology › JAZZ

Jazz Pharmaceuticals JAZZ

US equityMarket cap rank #1119Biotechnology
$230.26 −$6.19 (-2.62%)
Market closed · Nov 20, 8:20 pm ET · Last extended-hours $230.62 +0.16%
Open$235.19
Prev close$236.45
Day range$227.95 – $238.59
Volume984.7K
Market cap$14.78B
P/E (TTM)68.1
Dividend yield–

JAZZ Stock News

Headlines matching Jazz Pharmaceuticals or the JAZZ ticker, most recent first.

  • Citi Initiates Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Announces Target Price $325Market news · 30 Sep 2026 · Direct mention
  • Piper Sandler Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $310Market news · 28 Sep 2026 · Direct mention
  • Goldman Sachs Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $337 PositiveMarket news · 24 Sep 2026 · Direct mention
  • UBS Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $337Market news · 14 Sep 2026 · Direct mention
  • UBS Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $337 PositiveMarket news · 11 Sep 2026 · Direct mention
  • Barclays Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $271 PositiveMarket news · 10 Sep 2026 · Direct mention
  • TD Cowen Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $300Market news · 1 Sep 2026 · Direct mention
  • Truist Financial Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy RatingMarket news · 1 Sep 2026 · Direct mention
  • CCORF Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $300Market news · 1 Sep 2026 · Direct mention
  • Needham Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $310Market news · 31 Aug 2026 · Direct mention
  • RBC Capital Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Raises Target Price to $299 PositiveMarket news · 28 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $281 to $322Market news · 27 Aug 2026 · Direct mention
  • Morgan Stanley Maintains Jazz Pharmaceuticals(JAZZ.US) With Buy Rating, Maintains Target Price $283Market news · 13 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $283 to $315Market news · 12 Aug 2026 · Direct mention
  • A Quick Look at Today's Ratings for Jazz Pharmaceuticals(JAZZ.US), With a Forecast Between $273 to $307Market news · 11 Aug 2026 · Direct mention

Discussion

No comments yet — be the first to weigh in on JAZZ.

Sign in to join the discussion.

Scroll to Top